Filana Therapeutics, Inc. (FLNA)
0.7726
-0.04
(-4.49%)
USD |
NASDAQ |
Sep 11, 16:00
0.7726
0.00 (0.00%)
Pre-Market: 08:31
Filana Therapeutics Market Cap : 37.32M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 37.32M |
| September 10, 2026 | 39.08M |
| September 09, 2026 | 39.08M |
| September 08, 2026 | 38.51M |
| September 04, 2026 | 39.62M |
| September 03, 2026 | 40.01M |
| September 02, 2026 | 41.43M |
| September 01, 2026 | 41.41M |
| August 31, 2026 | 43.38M |
| August 28, 2026 | 44.88M |
| August 27, 2026 | 44.59M |
| August 26, 2026 | 44.66M |
| August 25, 2026 | 45.83M |
| August 24, 2026 | 44.93M |
| August 21, 2026 | 46.42M |
| August 20, 2026 | 45.53M |
| August 19, 2026 | 46.68M |
| August 18, 2026 | 41.88M |
| August 17, 2026 | 42.99M |
| August 14, 2026 | 44.12M |
| August 13, 2026 | 45.69M |
| August 12, 2026 | 45.09M |
| August 11, 2026 | 46.94M |
| August 10, 2026 | 48.18M |
| August 07, 2026 | 48.07M |
| Date | Value |
|---|---|
| August 06, 2026 | 46.33M |
| August 05, 2026 | 46.37M |
| August 04, 2026 | 48.13M |
| August 03, 2026 | 49.76M |
| July 31, 2026 | 48.79M |
| July 30, 2026 | 46.38M |
| July 29, 2026 | 42.01M |
| July 28, 2026 | 42.75M |
| July 27, 2026 | 43.50M |
| July 24, 2026 | 43.04M |
| July 23, 2026 | 45.03M |
| July 22, 2026 | 46.58M |
| July 21, 2026 | 48.79M |
| July 20, 2026 | 49.27M |
| July 17, 2026 | 51.21M |
| July 16, 2026 | 52.17M |
| July 15, 2026 | 53.14M |
| July 14, 2026 | 52.66M |
| July 13, 2026 | 55.55M |
| July 10, 2026 | 57.00M |
| July 09, 2026 | 57.49M |
| July 08, 2026 | 57.00M |
| July 07, 2026 | 63.28M |
| July 06, 2026 | 60.38M |
| July 02, 2026 | 59.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 607.74M |
| Eloxx Pharmaceuticals, Inc. | 63.57M |
| Cannabis Global, Inc. | 0.0066M |
| Breakthrough Chemistry, Inc. | 2.140M |
| BioStem Technologies, Inc. | 76.81M |
Market Cap Related Metrics
| Price to Book Value | 0.5868 |
| Price | 0.7726 |
| Earnings Yield | -113.3% |